These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 35018545)
1. Patients with end-stage renal disease requiring hemodialysis benefit from percutaneous coronary intervention after non-ST-segment elevation myocardial infarction. Fu Y; Sun H; Zuo K; Guo Z; Xu L; Chen M; Wang L Intern Emerg Med; 2022 Jun; 17(4):1087-1095. PubMed ID: 35018545 [TBL] [Abstract][Full Text] [Related]
2. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort. Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733 [TBL] [Abstract][Full Text] [Related]
3. ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction. Hishikari K; Kakuta T; Lee T; Murai T; Yonetsu T; Isobe M Catheter Cardiovasc Interv; 2016 Mar; 87(4):E113-21. PubMed ID: 26152334 [TBL] [Abstract][Full Text] [Related]
4. One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention. Liu HW; Han YL; Jin QM; Wang XZ; Ma YY; Wang G; Wang B; Xu K; Li Y; Chen SL Chin Med J (Engl); 2018 Jun; 131(12):1412-1419. PubMed ID: 29893357 [TBL] [Abstract][Full Text] [Related]
5. Outcome of Percutaneous Coronary Intervention During Non-ST-Segment-Elevation Myocardial Infarction in Elderly Patients With Chronic Kidney Disease. Holzmann MJ; Siddiqui AJ J Am Heart Assoc; 2020 Jun; 9(12):e015084. PubMed ID: 32519559 [TBL] [Abstract][Full Text] [Related]
6. Prognosis of patients with renal failure one year following non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. Januszek R; Bujak K; Kasprzycki K; Gąsior M; Bartuś S Hellenic J Cardiol; 2024; 76():48-57. PubMed ID: 37499942 [TBL] [Abstract][Full Text] [Related]
7. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system. Huang L; Zhang J; Huang Q; Cui R; Chen J BMC Cardiovasc Disord; 2023 Apr; 23(1):198. PubMed ID: 37069503 [TBL] [Abstract][Full Text] [Related]
8. Impact of chronic kidney disease on clinical outcomes in patients with non-ST elevation myocardial infarction receiving percutaneous coronary intervention - A five-year observational study. Wang HT; Chen YL; Wu CJ Int J Cardiol; 2016 Oct; 220():166-72. PubMed ID: 27379919 [TBL] [Abstract][Full Text] [Related]
9. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI. Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y Atherosclerosis; 2019 Jan; 280():166-173. PubMed ID: 30529829 [TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry. Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E; Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193 [TBL] [Abstract][Full Text] [Related]
11. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease. Perera D; Crake T; Lee V Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315 [TBL] [Abstract][Full Text] [Related]
12. Women with Acute Myocardial Infarction: Clinical Characteristics, Treatment, and In-Hospital Outcomes from a Latin American Country. Arias-Mendoza A; González-Pacheco H; Álvarez-Sangabriel A; Gopar-Nieto R; Rodríguez-Chávez LL; Araiza-Garaygordobil D; Ramírez-Rangel P; Martínez DS; Del Carmen Lacy-Niebla M; Briseño-De la Cruz JL; Juárez-Tolen J; Mendoza-García S; Altamirano-Castillo A Glob Heart; 2023; 18(1):19. PubMed ID: 37092023 [TBL] [Abstract][Full Text] [Related]
13. Sex-Related Differences in Short- and Long-Term Outcome among Young and Middle-Aged Patients for ST-Segment Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention. Fu WX; Zhou TN; Wang XZ; Zhang L; Jing QM; Han YL Chin Med J (Engl); 2018 Jun; 131(12):1420-1429. PubMed ID: 29893358 [TBL] [Abstract][Full Text] [Related]
14. Impact of residual coronary lesions on outcomes of myocardial infarction patients with multi-vessel disease. Ahmed TAN; Othman AAA; Demitry SR; Elmaghraby KM BMC Cardiovasc Disord; 2024 Jan; 24(1):68. PubMed ID: 38262995 [TBL] [Abstract][Full Text] [Related]
15. The management of non-culprit vessel(s) in patients with unstable angina/non-ST elevation myocardial infarction and chronic kidney dysfunction. Liao GZ; Li YM; Liu T; Bai L; Chen XF; Ye YY; Chai H; Peng Y Intern Med J; 2024 Mar; 54(3):473-482. PubMed ID: 37552622 [TBL] [Abstract][Full Text] [Related]
16. The impact of successful revascularization of coronary chronic total occlusions on long-term clinical outcomes in patients with non-ST-segment elevation myocardial infarction. Teng HI; Sung SH; Huang SS; Pan JP; Lin SJ; Chan WL; Lee WL; Lu TM; Wu CH J Interv Cardiol; 2018 Jun; 31(3):302-309. PubMed ID: 29495125 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of Non-ST-Segment Myocardial Infarction During Chronic Heart Failure and End-Stage Renal Disease. Alhuarrat MAD; Alhuarrat MR; Varrias D; Patel SR; Sims DB; Latib A; Jorde UP; Saeed O Am J Cardiol; 2023 Aug; 200():1-7. PubMed ID: 37269688 [TBL] [Abstract][Full Text] [Related]
18. The Prognostic Value of Cardiovascular Risk Factors and Laboratory Biomarkers in Predicting 6-Month Outcomes in High-risk Patients with Non-ST Segment Elevation Myocardial Infarction. Lubovich A; Issawy M; Grosman-Rimon L; Kusniec F; Marai I; Sudarsky D; Birati EY; Amir O; Carasso S; Elbaz-Greener G Isr Med Assoc J; 2023 Mar; 25(3):210-214. PubMed ID: 36946667 [TBL] [Abstract][Full Text] [Related]
19. Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry. Bagai A; Lu D; Lucas J; Goyal A; Herzog CA; Wang TY; Goodman SG; Roe MT J Am Heart Assoc; 2018 Dec; 7(24):e010394. PubMed ID: 30514137 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the cost in percutaneous coronary intervention between ST-segment elevation myocardial infarction vs. non-ST-segment elevation myocardial infarction. Murakami T; Sakakura K; Taniguchi Y; Yamamoto K; Tsukui T; Seguchi M; Jinnouchi H; Wada H; Fujita H Cardiovasc Interv Ther; 2022 Apr; 37(2):293-303. PubMed ID: 33884579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]